Caricamento...
Targeting the IκB Kinase Enhancer and Its Feedback Circuit in Pancreatic Cancer()
Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease with an overall median 5-year survival rate of 8%. This poor prognosis is because of the development of resistance to chemotherapy and radiation therapy and lack of effective targeted therapies. IκB kinase enhancer (IKBKE) overexpression wa...
Salvato in:
| Pubblicato in: | Transl Oncol |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Neoplasia Press
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6994835/ https://ncbi.nlm.nih.gov/pubmed/32004866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2019.11.009 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|